GSK

GSK (GSK)

GSK plc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:GSK

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/13	16 : 05	Business Wire	GSK Enters Agreement to Acquire IDRx, Inc.	NYSE:GSK	GSK plc
2025/01/03	00 : 07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/12/24	02 : 53	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/12/10	03 : 38	Business Wire	Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse	NYSE:GSK	GSK plc
2024/11/27	20 : 11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/11/25	21 : 13	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/11/22	23 : 21	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/11/20	00 : 53	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/11/19	22 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/11/14	20 : 44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/10/31	01 : 29	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/10/31	00 : 24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/10/30	19 : 35	IH Market News	Google Cloud Revenue Grows 35%; AMD Stock Drops 8%, Qorvo Plummets 18%, Reddit Surges 24% in Pre-Market	NYSE:GSK	GSK plc
2024/10/24	20 : 00	Business Wire	New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease	NYSE:GSK	GSK plc
2024/10/18	01 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/10/17	01 : 54	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/10/16	19 : 22	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/10/15	19 : 32	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/10/15	19 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/10/14	19 : 11	IH Market News	TSMC To Exceed Profits, Plans European Factories; Boeing Cuts 17,000 Jobs; Berkshire Boosts Sirius XM Stake	NYSE:GSK	GSK plc
2024/10/10	19 : 45	IH Market News	Tesla’s Robotaxi Day; GSK Settles 93% of Zantac Lawsuits; 10x Genomics Stock Drops on Revenue Forecast	NYSE:GSK	GSK plc
2024/10/08	20 : 00	Business Wire	GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons	NYSE:GSK	GSK plc
2024/10/03	21 : 45	InvestorsHub NewsWire	Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More	NYSE:GSK	GSK plc
2024/09/25	00 : 07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/09/24	19 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc
2024/09/19	21 : 00	GlobeNewswire Inc.	Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)	NYSE:GSK	GSK plc
2024/09/19	19 : 26	IH Market News	AIG names new CFO; Progyny Drops 24% After Losing Key 2025 Contract; Exicure Jumps 190% With Nasdaq Extension	NYSE:GSK	GSK plc
2024/09/18	20 : 00	Business Wire	GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX	NYSE:GSK	GSK plc
2024/09/17	02 : 04	PR Newswire (US)	Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk	NYSE:GSK	GSK plc
2024/09/13	19 : 29	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:GSK	GSK plc